SUBSCRIBE
SUBSCRIBE
Gail Dutton

Gail Dutton

Freelance writer

Gail Dutton is a veteran biopharmaceutical reporter, covering the industry from Washington state. You can contact her at gaildutton@gmail.com and see more of her work on Muckrack.

Business
Genetika+ CEO Talia Cohen Solal Brings Precision Medicine to Brain Health
Depression is the first indication, but other neurological conditions are being planned.
October 20, 2021
 · 
5 min read
 · 
Gail Dutton
Innovative New Approach Sequences One Million Single Cells in Parallel
Parse Biosciences’ multiplexed approach enables 96 samples and a total of 1 million single cells to be analyzed in parallel without the need for specialized lab instruments.
October 20, 2021
 · 
4 min read
 · 
Gail Dutton
Pictured: Selecta CEO Carsten Brunn/courtesy Selec
Drug Development
Gene Therapy Redosing Gains Traction as Need Grows and Novel Strategies Emerge
Redosing is a large and growing concern for gene therapy developers and regulators.
October 19, 2021
 · 
4 min read
 · 
Gail Dutton
BioCapital
Overcoming Myths that Slow Investment in Biotech and Pandemic Companies
Peter Adams and Dave Harris at Rockies Venture Club (the oldest angel investment group in the U.S.) explored those myths and offered strategies to counter them.
October 18, 2021
 · 
5 min read
 · 
Gail Dutton
Courtesy of Getty Images
Biotech Bay
Cell & Gene Therapy: Balancing Hope & Promise for Sickle Cell Therapies
Biopharma companies recognized that developing a therapy is merely the beginning of what is needed to connect patients with sickle cell disease to next-level therapies.
October 17, 2021
 · 
5 min read
 · 
Gail Dutton
Drug Development
Telix’s MTRs are Advancing the Field of Precision Radio-Oncology
Modern radiation therapy is tightly targeted to dramatically reduce toxicity and side effects and often can be administered on an outpatient basis.
October 13, 2021
 · 
4 min read
 · 
Gail Dutton
Deals
Cue Health is Transforming Healthcare with At-Home, PoC Diagnostics
Cue Health went public on September 24 on the Nasdaq securities exchange under the ticker symbol HLTH.
October 12, 2021
 · 
3 min read
 · 
Gail Dutton
Drug Development
For Kezar Life Sciences’ John Fowler, Variety Truly is the Spice of Life
Variety, passion and the ability to make tangible improvements in people’s lives have propelled John Fowler, co-founder and CEO of Kezar Life Sciences, throughout his career.
October 11, 2021
 · 
5 min read
 · 
Gail Dutton
Drug Development
Arcus is Uncloaking Cancer with Well-Informed Optimism
This year – 2021 – will be a transformational year, Rosen predicted, citing three important milestones.
October 10, 2021
 · 
4 min read
 · 
Gail Dutton
Drs. Neely Mozaffarian and Hong Sun, Janssen Immun
Business
Stakeholder Collaborations Essential to Making Things Happen in Rare Disease Space
Patients and patient organizations, which have detailed insights in the natural history of a rare disease, should be integral, too.
October 7, 2021
 · 
4 min read
 · 
Gail Dutton
Drug Development
3D-Printed Vaccine Patch Offers Enhanced Immune Response, Comfort Level
The patch is not only painless, it requires less vaccine to generate the same or greater effects.
October 6, 2021
 · 
4 min read
 · 
Gail Dutton
Drug Development
Rejuvenate Bio is Reversing Age-Related Diseases to Increase Healthspan
Unlike most companies addressing the diseases associated with aging, Rejuvenate Bio tackles multiple cardiac, metabolic and renal issues at once.
October 5, 2021
 · 
5 min read
 · 
Gail Dutton
Drug Development
AACC Buzz: Noninvasive Blood or Saliva Tests for Cancer and COVID-19 Are Promising
Noninvasive tests for colorectal cancer, prostate cancer and COVID-19 were among the highlights of the American Association for Clinical Chemistry meeting September 26-30.
October 1, 2021
 · 
4 min read
 · 
Gail Dutton
Business
Novel CAR T Therapies Help Celyad’s CMO Bring Hope to Fearful Patients
Celyad is focusing on advancing chimeric antigen receptor T cell (CAR T) therapies.
September 28, 2021
 · 
5 min read
 · 
Gail Dutton
Psychiatry on the Brink: Precision Medicine Finally Streamlines Therapeutic Selection
Eriksson said that HMNC Brain Health is a pioneer in developing precision medicine for the psychiatric space.
September 27, 2021
 · 
4 min read
 · 
Gail Dutton
Load More